Natalizumab Versus Fingolimod in Patients with Relapsing-Remitting Multiple Sclerosis: A Subgroup Analysis From Three International Cohorts

被引：0

作者：

Sifat Sharmin

Mathilde Lefort

Johanna Balslev Andersen

Emmanuelle Leray

Dana Horakova

Eva Kubala Havrdova

Raed Alroughani

Guillermo Izquierdo

Serkan Ozakbas

Francesco Patti

Marco Onofrj

Alessandra Lugaresi

Murat Terzi

Pierre Grammond

Francois Grand’Maison

Bassem Yamout

Alexandre Prat

Marc Girard

Pierre Duquette

Cavit Boz

Maria Trojano

Pamela McCombe

Mark Slee

Jeannette Lechner-Scott

Recai Turkoglu

Patrizia Sola

Diana Ferraro

Franco Granella

Julie Prevost

Davide Maimone

Olga Skibina

Katherine Buzzard

Anneke Van der Walt

Bart Van Wijmeersch

Tunde Csepany

Daniele Spitaleri

Steve Vucic

Romain Casey

Marc Debouverie

Gilles Edan

Jonathan Ciron

Aurélie Ruet

Jérôme De Sèze

Elisabeth Maillart

Hélène Zephir

Pierre Labauge

Gilles Defer

Christine Lebrun-Frénay

Thibault Moreau

Eric Berger

机构：

[1] University of Melbourne,CORe, Department of Medicine

[2] Rennes University,The Danish Multiple Sclerosis Registry, Department of Neurology

[3] EHESP,Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine

[4] REPERES,Division of Neurology, Department of Medicine

[5] EA,Department of Medical and Surgical Sciences and Advanced Technologies

[6] Univ Rennes,Multiple Sclerosis Center

[7] CHU Rennes,Department of Neuroscience, Imaging, and Clinical Sciences

[8] Inserm,Dipartimento di Scienze Biomediche e Neuromotorie

[9] CIC 1414 (Centre d’Investigation Clinique de Rennes),Medical Faculty

[10] University of Copenhagen,Nehme and Therese Tohme Multiple Sclerosis Center

[11] Charles University in Prague and General University Hospital,Department of Basic Medical Sciences, Neuroscience and Sense Organs

[12] Amiri Hospital,College of Medicine and Public Health

[13] Hospital Universitario Virgen Macarena,School of Medicine and Public Health

[14] Dokuz Eylul University,Department of Neurology, John Hunter Hospital

[15] GF Ingrassia,Department of Neuroscience

[16] University of Catania,Department of Medicine and Surgery

[17] University G. d’Annunzio,Department of Emergency and General Medicine

[18] IRCCS Istituto delle Scienze Neurologiche di Bologna,Neurology Unit

[19] Università di Bologna,Department of Neuroscience

[20] 19 Mayis University,Department of Neurology

[21] CISSS Chaudière-Appalache,Central Clinical School

[22] Neuro Rive-Sud,Department of Neurology, Faculty of Medicine

[23] American University of Beirut Medical Center,Neurophysiology Department

[24] CHUM MS Center and Universite de Montreal,Service de neurologie, sclérose en plaques, pathologies de la myéline et neuro

[25] KTU Medical Faculty Farabi Hospital,inflammation, Hôpital Neurologique Pierre Wertheimer

[26] University of Bari,Department of Neurology

[27] University of Queensland,Department of Neurology

[28] Royal Brisbane and Women’s Hospital,Neurocentre Magendie

[29] Flinders University,Department of Neurology

[30] University Newcastle,Département de neurologie

[31] Hunter New England Health,MS Unit

[32] Haydarpasa Numune Training and Research Hospital,Department of Neurology, CHU de Caen, MS Expert Centre

[33] Azienda Ospedaliera Universitaria,Department of Neurology

[34] University of Parma,Department of Neurology

[35] Parma University Hospital,Department of Neurology

[36] CSSS Saint-Jérôme,Department of Neurology

[37] Garibaldi Hospital,Department of Neurology

[38] Monash University,Department of Neurology

[39] The Alfred Hospital,Department of Neurology

[40] Monash University,Department of Neurology

[41] Rehabilitation and MS-Centre Overpelt and Hasselt University,Department of Neurology

[42] University of Debrecen,Department of Neurology

[43] Azienda Ospedaliera di Rilievo Nazionale San Giuseppe Moscati Avellino,Department of Neurology

[44] Westmead Hospital,Department of Neurology

[45] Université de Lyon,CRC SEP and Department of Neurology

[46] Université,Department of Neurology

[47] Hospices Civils de Lyon,Department of Neurology

[48] Observatoire Français de la Sclérose en Plaques,Department of Neurology

[49] Centre de Recherche en Neurosciences de Lyon,Department of Neurology

[50] INSERM 1028 et CNRS UMR 5292,Department of Neurology

来源：

CNS Drugs | 2021年 / 35卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：1217 / 1232

页数：15

共 50 条

[21] Natalizumab in spinal relapsing-remitting multiple sclerosis
Zecca, C.
Kamm, C.
Riccitelli, G. C.
Heldner, M.
Caporro, M.
Gobbi, C.
EUROPEAN JOURNAL OF NEUROLOGY, 2014, 21 : 457 - 457
[22] Predicting response to fingolimod in patients with relapsing-remitting multiple sclerosis
Giuliani, M.
Prosperini, L.
Fanelli, F.
Hirsch, M. N.
De Angelis, F.
Pozzilli, C.
MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 306 - 306
[23] Effectiveness of cladribine compared to fingolimod, natalizumab, ocrelizumab and alemtuzumab in relapsing-remitting multiple sclerosis
Roos, Izanne
Sharmin, Sifat
Malpas, Charles
Ozakbas, Serkan
Lechner-Scott, Jeannette
Hodgkinson, Suzanne
Alroughani, Raed
Izquierdo, Guillermo
Eichau Madueno, Sara
Boz, Cavit
van der Walt, Anneke
Butzkueven, Helmut
Buzzard, Katherine
Skibina, Olga
Foschi, Matteo
Grand'Maison, Francois
John, Nevin
Grammond, Pierre
Terzi, Murat
Prevost, Julie
Barnett, Michael
Laureys, Guy
Van Hijfte, Liesbeth
Luis Sanchez, Jose
Blanco, Yolanda
Oh, Jiwon
Mccombe, Pamela
Ramo Tello, Cristina
Soysal, Aysun
Prat, Alexandre
Girard, Marc
Duquette, Pierre
Yamout, Bassem I.
Khoury, Samia
Van Pesch, Vincent
Macdonell, Richard
Sa, Maria Jose
Slee, Mark
Kuhle, Jens
Maimone, Davide
Spitaleri, Daniele L. A.
Willekens, Barbara
Al-Asmi, Abdullah
Robertson, Neil
Coles, Alasdair
Brown, J. William L.
Kalincik, Tomas
MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 629 - 631
[24] Natalizumab: safety and risk in patients with relapsing-remitting multiple sclerosis
Rodriguez de Castro, Belen
Martinez-Mugica Barbosa, Cristina
Ayastuy Ruiz, Aitor
Fernandez Gonzalez, Beatriz
EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2021, 28 (02) : 112 - 114
[25] Natalizumab reduces apathy in relapsing-remitting multiple sclerosis patients
Berkovich, R.
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2011, 21 : S154 - S155
[26] Natalizumab use in pediatric patients with relapsing-remitting multiple sclerosis
Arnal-Garcia, Carmen
Rosa Garcia-Montero, Ma
Malaga, Ignacio
Millan-Pascual, Jorge
Oliva-Nacarino, Pedro
Ramio-Torrenta, Lluis
Oreja-Guevara, Celia
EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY, 2013, 17 (01) : 50 - 54
[27] Effectiveness of cladribine compared to fingolimod, natalizumab, ocrelizumab and alemtuzumab in relapsing-remitting multiple sclerosis
Roos, Izanne
Sharmin, Sifat
Malpas, Charles
Ozakbas, Serkan
Lechner-Scott, Jeannette
Hodgkinson, Suzanne
Alroughani, Raed
Eichau Madueno, Sara
Boz, Cavit
van der Walt, Anneke
Butzkueven, Helmut
Buzzard, Katherine
Skibina, Olga
Foschi, Matteo
Grand'Maison, Francois
John, Nevin
Grammond, Pierre
Terzi, Murat
Prevost, Julie
Barnett, Michael
Laureys, Guy
Van Hijfte, Liesbeth
Luis Sanchez-Menoyo, Jose
Blanco, Yolanda
Oh, Jiwon
Mccombe, Pamela
Ramo Tello, Cristina
Soysal, Aysun
Prat, Alexandre
Duquette, Pierre
Yamout, Bassem, I
Khoury, Samia
van Pesch, Vincent
Macdonell, Richard
Jose Sa, Maria
Slee, Mark
Kuhle, Jens
Maimone, Davide
Spitaleri, Daniele L. A.
Willekens, Barbara
Asmi, Abdallah Al
Tallantyre, Emma
Robertson, Neil P.
Coles, Alasdair
Brown, J. William
Kalincik, Tomas
MULTIPLE SCLEROSIS JOURNAL, 2024,
[28] Efficacy of natalizumab and fingolimod in relapsing-remitting multiple sclerosis in real world clinical practice
Totaro, R.
Costantino, G.
Bellantonio, P.
Danni, M.
Di Carmine, C.
Fantozzi, R.
Cerqua, R.
Fuiani, A.
Mundi, C.
Ruggieri, S.
Marini, C.
Provinciali, L.
Carolei, A.
MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 267 - 267
[29] Cost minimisation analysis of fingolimod vs natalizumab as a second line of treatment for relapsing-remitting multiple sclerosis
Crespo, C.
Izquierdo, G.
Garcia-Ruiz, A.
Granell, M.
Brosa, M.
NEUROLOGIA, 2014, 29 (04): : 210 - 217
[30] Fingolimod reduces direct medical costs compared to natalizumab in patients with relapsing-remitting multiple sclerosis in the Netherlands
Heisen, M.
Treur, M. J.
van der Hel, W. S.
Groot, M. T.
Verheggen, B. G.
JOURNAL OF NEUROLOGY, 2012, 259 : S67 - S68

← 1 2 3 4 5 →